Previous studies have reported that CHK1 inhibition sensitized cancer cells to gemcitabine19–21, silencing of the FA Pathway genes enhanced cytotoxicity of cisplatin to lung cancer cells24,26. This evidence concerns the gene CHEK1 and cancer.